Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
97 Leser
Artikel bewerten:
(0)

Global Blood Testing Market 2017-2021 - Thriving Demand for POCT / Increasing Adoption of Sutomation

DUBLIN, November 28, 2017 /PRNewswire/ --

The "Global Blood Testing Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global blood testing market to grow at a CAGR of 2.82% during the period 2017-2021.

Global Blood Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from retail sales of blood testing equipment, which includes instruments, reagents, and consumables.

One trend in the market is thriving demand for POCT. The diagnostics business market is undergoing revolutionary change, with the devices getting smaller in size, the customary focal research centers moving to close patient locales, and growing test menus due to the increasing adoption of multiparameter monitoring devices.

According to the report, one driver in the market is high demand for RDTs. RDTs are medical tests that are quick and easy to perform. They are suitable for preliminary or emergency medical screening, and can be performed in medical facilities with limited resources. They also allow POC testing in primary care, which was earlier limited to laboratories. They provide results within two hours, typically in approximately 20 minutes. Hence, laboratory methods that require more than one hour to provide a clear diagnosis of disease are not considered rapid tests.

Further, the report states that one challenge in the market is lack of trained professionals. Effective translation of diagnostics from the research phase to the application phase presents challenges. For instance, blood testing requires extensive optimization before results can be interpreted correctly. Therefore, clinical laboratories require trained specialists. However, there is a shortage of these specialists in diagnostic centers and hospitals worldwide. Most rural hospitals in the US face issues such as lack of required patient volume to justify having specialists who charge a premium for performing additional tests.

Market trends

  • Thriving demand for POCT
  • Increasing adoption of automation in healthcare sector
  • Increasing number of blood donations

Key vendors

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • F. Hoffmann La Roche
  • Siemens Healthineers

Other prominent vendors

  • bioMerieux
  • Cardinal Health
  • Cepheid
  • Danaher
  • Novartis
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Trividia Health

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By End-User

Part 07: Regional Landscape

Part 08: Decision Framework

Part 09: Drivers And Challenges

Part 10: Market Trends

Part 11: Vendor Landscape

Part 12: Key Vendor Analysis

Part 13: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/4p4ph4/global_blood

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.